Farmavita.Net - Pharmaceutical Licensing Network

Home

Seeking: Novel new sensations and materials for lip products

A kiss may be just a kiss, but we're looking for unique materials to add to lip products for new lip sensations and
experiences (such as cooling, warming, numbing, tingling and flavors), solutions that can impart prolonged sensate
experiences, and solutions that can impart not-yet-known sensations.

Innovative Medicines Offer

Victory Pharmaceuticals - Late Stage Development Program in Pain Management

Development-stage pain products

The Company seeks to divest its development-stage pain products MGX-001 (extended release morphine combined with an atypical stimulant) and MGX-002 (a follow-on opioid combined with an atypical stimulant). These products are expected to significantly reduce commonly-experienced side effects versus existing opiate therapies.

Generic Medicine Demand

Medicines required

Intermediary Pharma Group from Azerbaijan, is interested in obtaining the following finished pharmaceutical products for permanent partnership with full dossiers for registration:

Ceftriaxon 1g, 0.5g with ligocaine;

Ampicilline +Sulbactam 1.5g with solvent;

Cefotaxime 1g, 0.5g,with lidocaine;

Amikacine.

Generic Medicines - Offer

Levetiracetam

There is on-going development of generic EU CTD Dossier of Levetiracetam, tablets, 250/500/750/1000 mg.

DCP slot confirmed.

Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights.

OTC / Nutraceutical Demand

N-acetylcysteine

N-acetylcysteine 1200 mg effervescent tablets

Reference Product:

Name of the product: Fluimucil 600

Name of the company: Zambon Spa

Patent expiry date: N/A

Dossier:

Language: English

Format: EU CTD

API/Technology Demand

Fermentation Technologies

Bacteria strains and fermentation technologies

Farmavita.Net member is seeking bacteria strains and fermentation technologies to produce the following products Lycopene, Chlortetracycline and Acetylisovaleryltylosin.

Open Innovation

McKinesey Quarterly

Using knowledge brokering to improve business processes

Over the past decade, open innovation has begun transforming the way global companies develop new products, as executives increasingly recognize the benefits of exposing internal R&D to outside ideas. Now, some organizations are going even further by applying open-source thinking to improve a range of core business processes. Aided by rapidly changing technology, these leaders are looking outside the gates to develop faster and better solutions to a variety of strategic, operational, and organizational problems.

Download free 9 pages report at our Download Section.

Life Science Article

Calotropis procera

ANTI-DIARRHEAL ACTIVITY OF ETHANOLIC EXTRACT OF CALOTROPIS PROCERA R. Br. ROOTS

Calotropis procera R. Br. (Asclepidaceae) is a shrub which widely distribute in the world. The plant is used in the treatment of many disease and disorder both in humans and veterinary application. The present work was undertaken to investigate the anti-diarrhoeal activity of ethanolic extract of root (200 mg/kg BW) of Calotropis procera against castor oil induced diarrhoea in experimental animal and was found to be significant results.

The whole 6 pages article is available for download at Downloads section of Farmavita.Net.

Events

Pricing & Reimbursement Models

2nd Annual Pharmaceutical

Risk-Sharing & Value-Based Pricing & Reimbursement Models

April 15-16, 2010 - Vienna, Austria

There is clearly an increasing need for more innovative pricing and reimbursement agreements to help to balance the often conflicting objectives of pharmaceutical and medical technology manufacturers, payers, health technology assessors (HTA), physicians and patients. The industry faces a sustained increase in the cost of healthcare and an ever-increasing range of expensive drugs and technologies available as potential therapies.

Market Report

Medical Aesthetic Devices Market

The Future of the Medical Aesthetic Devices Market to 2016 - The Market to Regain Positive Growth

GBI Research's new report, "The Future of the Aesthetic Devices Market to 2016 - The Market to Regain Positive Growth" provides key data, information and analysis on the global aesthetic devices market. The report provides market landscape, competitive landscape and market trends information on three medical aesthetic devices market categories - Aesthetic Lasers and Energy Devices, Facial Aesthetics and Breast Implants. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Claim "10% Discount for Farmavita.Net Members" when purchasing this report!

Networking Tips & Tricks

Monitoring Downloads Section

You can easily monitor all new articles and reports published at Downloads Section of Farmavita.Net. Click on the RSS button and bookmark this RSS feed. RSS button is located beside title “Farmavita.Net - Pharmaceutical Licensing Network :: File Repository“.